DTU Logo
About the DTU | News | Staff | Alumni | Contact/Find us

Professor Rury Holman



Conference Abstracts (93 of 93)


Search Conference Abstracts :

2016

52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Sitagliptin and risk of fractures in type 2 diabetes: results from the TECOS trial
R.G. Josse, S.R. Majumdar, Y. Zheng, J.B. Buse, J.B. Green, K.D. Kaufman, E.D. Peterson, R.R.Holman, P.W. Armstrong, on behalf of the TECOS Study Group
Diabetologia 2016;59:Suppl 1:S372
[Abstract]
52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Impact of sitagliptin on cardiovascular and safety-related outcomes in insulin-treated type 2 diabetes: the TECOS experience
M.A. Bethel, S.S. Engel, J. Ding, R.G. Josse, R.R. Holman and the TECOS Study Group
Diabetologia 2016;59:Suppl 1:S369
[Abstract] [Poster]
52nd Annual Meeting of the European Association for the Study of Diabete, Munich (Poster)
Assessing the safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
S.S. Engel, S. Suryawanshi, R.G. Josse, E.D. Peterson, R.R. Holman and the TECOS Study Group
Diabetologia 2016;59:Suppl 1:S361
[Abstract] [Poster]
52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Stimulatory effects of the long - acting kisspeptin analogue TAK - 448 on serum testosterone in men with type 2 diabetes and hypogonadotropic hypogonadism
J.T. George, J.E. Milton, A.E. Cooper, S. Greentree, R.A. Anderson and R.R. Holman
Diabetologia 2016;59:Suppl 1:S228-S229
[Abstract] [Poster]
52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Estimated 10-year benefit for diabetes complication rates by 1% HbA1c decrements in people with type 2 diabetes and cardiovascular disease
S.A. Mostafa, R.R. Holman, R.L. Coleman, O. Agbaje, M.A. Bethel
Diabetologia 2016;59:Suppl 1:S543
[Abstract] [Poster]
52nd Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
Sex differences in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
J.B. Green, J. Alfredsson, S.R. Stevens, S.D. Reed, D.K. McGuire, P.W. Armstrong, S.S. Engel, M.A. Bethel, F. Van de Werf, E.D. Peterson, R.R. Holman
Diabetologia 2016;59:Suppl 1:S544
[Abstract] [Poster]

2015

American Diabetes Association (ADA) Conference, Boston, USA (Poster)
Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly-diagnosed type 2 diabetes
Ruth L. Colman, Rury R. Holman
Diabetes 2015;64:1:A440

2014

American Diabetes Association (ADA) Conference, San Diego, CA (Poster)
Effects of Long-term, Monthly Administration of the PCSK9 Inhibitor Evolocumab in Patients with Dysglycemia or Metabolic Syndrome
Robert R. Henry, Rury R. Holman, Robert P. Giugliano, Frederick J. Raal, David Sullivan, Nariman Honarpour, Patric Nelson, Mary Elliott, Thomas Liu, Scott M. Wasserman, Michael J. Koren
Diabetes Care 2014;63 supp 1:A157

2012

American Diabetes Association (ADA) Conference, Philadelphia, USA (Poster)
Updated UKPDS Risk Engine that Estimates Primary and Secondary Cardiovascular Disease Risk in People With Recently-Diagnosed or Established Type 2 Diabetes
Coleman RL, Stevens RJ, Holman RR
Diabetes 2012;61:Supp 1:A103
[Abstract]
15th International & 14th European Congress of Endocrinology, Florence, Italy (Poster)
Time course of the glucose legacy effect
R. Holman
Endocrine Abstracts 2012;29:S9.3
Diabetes UK Annual Professional Conference, Glasgow, UK (Poster)
A self-administered oral glucose tolerance test
MA Bethel, H Sourij, S White, L Tucker, I Kennedy, R Coleman, A Ring and RR Holman
Diabetic Medicine 2012;2012 Sup 1:47
[Poster]

2011

39th Meeting of the British Society for Paediatric Endocrinology and Diabetes, London, UK (Poster)
Early intervention in type 2 diabetes mellitus
Rury Holman
Endocrine Abstracts 2011;27:S22

2009

Diabetes UK Annual Professional Conference, Glasgow (Poster)
Addition of exenatide therapy to insulin treatment in individuals with type 2 diabetes
Price HC, Holman RR, Levy JC, Ayyagari U.
Diabetic Medicine 2009;26:Suppl 1:141
[Abstract]
Diabetes UK Annual Professional Conference, Glasgow (Poster)
Addition of Exenatide therapy to oral blood glucose lowering treatment in individuals with Type 2 diabetes
Ayyagari U, Holman RR, Levy JC, Price HC
Diabetic Medicine 2009;26:Suppl 1:141
[Abstract]
69th Scientific Session of the American Diabetes Association, New Orleans (Poster)
Unravelling the Dynamics of Insulin Dose and Changes in Weight and HbA1c
Paul SK, Holman RR
Diabetes 2009;58:Suppl 1:A163
[Abstract]
69th Scientific Session of the American Diabetes Association, New Orleans (Publication only)
Rationale and Design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
Bethel MA, Green J, Califf RM, Holman RR
Diabetes 2009;59:Suppl 1:A555
[Abstract]
69th Scientific Session of the American Diabetes Association, New Orleans (Publication only)
Physical Activity in Adults at High Risk of Cardiovascular Disease
Price HC, Griffin SJ, Holman RR
Diabetes 2009;58:Suppl 1:A587
[Abstract]
69th Scientific Session of the American Diabetes Association, New Orleans (Publication only)
Prevalence of Undiagnosed Dysglycaemia in Adults at High Risk of Cardiovascular Disease
Price HC, Griffin SJ, Holman RR
Diabetes 2009;58:Suppl 1:A639
[Abstract]
69th Scientific Session of the American Diabetes Association, New Orleans (Poster)
Differences in Insulin Treatment Satisfaction Following Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes
Farmer AJ, Oke J, Stevens R, Holman RR
Diabetes 2009;58:Suppl 1:A130
[Abstract]
69th Scientific Session of the American Diabetes Association, New Orleans (Publication only)
Do Glycoalbumin Levels Preferentially Reflect Postprandial Glucose Excursions?
Hartweg J, Paul SJ, Fisher K, Carter R, Klyne R, Holman RR
Diabetes 2009;58:Suppl 1:A505
[Abstract]

2008

The Diabetes UK Annual Professional Conference, Glasgow (Poster)
The UKPDS Life Expectancy Calculator for Individuals with Type 2 diabetes
Price HC, Kennedy I, Clarke PM, Gray AM and Holman RR.
Diabetic Medicine 2008;25:suppl 1:63
[Abstract]
44th Annual Meeting of the European Association for the Study of Diabetes, Rome (Poster)
Performance of the UKPDS Risk Engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort
Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ
Diabetologia 2008;51:Suppl 1:S549
[Abstract]
44th Annual Meeting of the European Association for the Study of Diabetes, Rome (Poster)
Characteristics of patients requiring planned modification to regimen allocation during the first year of the 4-T Trial: need for twice-daily basal insulin or addition of a second insulin formulation
Levy JC, Farmer AJ, Thorne KI, Paul SK, Darbyshire JL, Davies MJ, Holman RR
Diabetologia 2008; (Accepted)
[Abstract]
68th Scientific Session of the American Diabetes Association, San Francisco (Oral)
Continuous Glucose Monitoring Results from the Treating to Target in Type 2 Diabetes (4-T) Trial
Davies MJ, Levy JC, Thorne KI, Paul SK, Darbyshire JL, Holman RR.
Diabetes 2008;57:(Suppl 1):A12
[Abstract]
International Biometric Conference, Dublin (Oral)
A Generalized Autoregressive Conditional Heteroscedasticity Model (GARCH) to Analyze Continuous Blood Glucose Monitoring Data for Diabetic Patients
Sanjoy PK, Holman RR
International Biometric Society 2008;978-0-9821919-0-3
[Abstract]
International Biometric Conference, Dublin (Oral)
Statistical Analysis of 8-Point Self Measured Capillary Glucose Profiles in Type 2 Diabetic Patients to Compare the Efficacy of Three Different Insulin Regimens
Paul SK, Thorne KI, Holman RR
International Biometric Society 2008;978-0-9821919-0-3
[Abstract]

2007

2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
Does metformin prevent cardiovascular events?
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S26
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
Abdominal obesity, metabolic syndrome and global cardiometabolic risk
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S37
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
A new era in the secondary prevention of CVD in prediabetes - the Acarbose Cardiovascular Evaluation (ACE) trial
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S40
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral)
The expanding evidence base - what have we added to our understanding of diabetes disease modification?
Holman RR
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S43-S44
[Abstract]
2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Poster)
Acarbose Cardiovascular Evaluation (ACE) Trial in prediabetic subjects
Holman RR, Pan CY
Diabetes & Vascular Disease Research 2007;4:Suppl 1:S128
[Abstract]
67th Scientific Session of the American Diabetes Association, Chicago (Poster)
The Oxford Risk Engine: A Cardiovascular Risk Calculator for Individuals with or without Type 2 diabetes
Coleman RL, Stevens RJ, Holman RR
Diabetes 2007;56:Suppl 1:A170
[Abstract]
The Diabetes UK Annual Professional Conference, Glasgow (Poster)
Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
Coleman RL, Stevens RJ, Holman RR
Diabetic Medicine 2007;24:Suppl 1:56
[Abstract]
67th Scientific Session of the American Diabetes Association, Chicago (Publication only)
Life-expectancy in Individuals with Type 2 Diabetes: Implications for Annuities.
Price HC, Cull CA, Clarke PM, Gray AM and Holman RR
Diabetes 2007;56:Suppl 1:A596
[Abstract]
The Diabetes UK Annual Professional Conference, Glasgow (Poster)
Framingham Equations Underestimate Cardiovascular Risk Compared with the UKPDS Risk Engine in People with Type 2 Diabetes.
Price HC, Cull CA, Coleman RL, Stevens RJ and Holman RR
Diabetic Medicine 2007;24:suppl 1:55
[Abstract]
28th Annual Conference of the International Society for Clinical Biostatistics, Alexandroupolis (Oral)
Modelling Continuous Glucose Monitoring Data: A Statistical Challenge
Paul SK, Holman RR
ISCB Abstracts 2007;117
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
Are measures of adiposity associated independently with incident cardiovascular disease in individuals with newly diagnosed type 2 diabetes?
Coleman RL, Holman RR
Diabetologia 2007;50:Suppl 1:S502
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral)
Increased incidence of fractures in women who received rosiglitazone in ADOPT (A Diabetes Outcome Progression Trial)
Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral)
Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain
Haffner SM, Kahn SE, Zinman B, Holman R, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral)
The distribution of macular hard exudates is related to future visual acuity in subjects with type 2 diabetes
Stratton IM, Scanlon PH, Holman RR, Stirling RJ, Lipinsk HL, Aldington SJ
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
Gloyn AL, van de Bunt M, Stratton I, Tucker L, Lonie L, Ellard S, Holman RR
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
Determinants of monotherapy failure in ADOPT (A Diabetes Outcome Progression Trial)
Holman RR, Kahn SE, S. Haffner M, Zinman B, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007; (Accepted)
[Abstract]
43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster)
ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes
Herman WH, Haffner SM, Kahn SE, Zinman B, Holman RR, Viberti GF, Lachin JM, Kravitz BG, Heise MA
Diabetologia 2007; (Accepted)
[Abstract]

2006

Diabetes UK, Birmingham (Poster)
Estimating risk of clinically evident neuropathy in type 2 diabetes: a UKPDS risk equation
Coleman RL, Stevens RJ, Holman RR
Diabetic Medicine 2006;23:Suppl. 2:51
66th Scientific Session of the American Diabetes Association, Washington DC (Oral)
Estimating Risk of Clinically Evident Retinopathy in Type 2 Diabetes.
Coleman RL, Stevens RJ, Aldington SJ, Holman RR
Diabetes 2006;55:Suppl 1:A53
27th Annual Conference of The International Society for Clinical Biostatistics, Geneva (Poster)
Nonparametric regression techniques for inference in highly skewed quality of life data - a case study with LDS diabetes patients using sf-36 scores
Paul SK, Holman RR
ISCB2006 Abstract Book 2006;215
Diabetes UK, Birmingham (Poster)
Treating to target in Type 2 diabetes (4-T) study of analogue insulin initiation and titration
Farmer AJ, Thorne KA, Stratton IM, Davies M, Keenan J, Teo E, Levy J, Holman RR
Diabetic Medicine 2006;23:Suppl 2:85
[Abstract]
Diabetes UK, Birmingham (Poster)
LDL cholesterol levels alone do not adequately assess coronary heart disease risk in Type 2 diabetes
Farmer AJ, Paul S, Stratton IM, Tucker L, Neil HAW, Holman RR
Diabetic Medicine 2006;23:Suppl 2:89
[Abstract]
66th Scientific Session of the American Diabetes Association, Washington DC (Publication only)
LDL Cholesterol Level Alone does not Assess Coronary Heart Disease Risk Adequately in Type 2 Diabetes
Farmer AJ, Paul SK, Stratton IM, Tucker L, Neil AW and Holman RR
Diabetes 2006;55:Suppl 1:A462
[Abstract]

2005

65th Scientific Sessions of the American Diabetes Association, San Diego (Poster)
A Cardiovascular Risk Calculator for Type 2 Diabetes
Coleman RL, Stevens RJ, Matthews DR, Holman RR
Diabetes 2005;54:Suppl 1:A172
41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral)
Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Coleman RL, Stevens RJ, Holman RR
Diabetologia 2005;48:Suppl 1:A32
41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral)
FPG and HbA1c are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
Kim JI, Stevens RJ, Holman RR
Diabetologia 2005;48:Suppl 1:A33
[Abstract]
41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral)
Susceptibility for latent autoimmune diabetes in adults (LADA) is determined by variation at the IDDM2 (insulin-gene) locus in white Caucasian patients from UK repositories
Desai M, Zeggini E, Owen KR, Holman RR, Levy JC, Hattersley AT, Hitman GA, Walker M, McCarthy MI, Clark A
Diabetologia 2005;48:Suppl1:A86
[Abstract]
41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral)
Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
Clark A, Desai M, Cull CA, Horton VA, Christie MR, Bingley PJ, Bonifacio E, Levy JC, Holman RR
Diabetologia 2005;48:Suppl 1:A86
[Abstract]
41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Poster)
Genotype and beta cell response to therapy in a large type 2 diabetic cohort
Powell BL, Stratton IM, Holman RR, McCarthy MI
Diabetologia 2005;48:Suppl 1:A101-A102
[Abstract]
Diabetes UK Annual Professional Conference, Glas (Poster)
AFORRD: a multi-centre trial evaluating potential cardiovascular risk reduction in patients with type 2 diabetes randomised in a factorial design to atorvastatin and/or omega-3 polyunsaturated fatty acids
Farmer AJ,Neil HAW, Holman RR
Diabetic Medicine 2005;22:S2:63
[Abstract]

2004

40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral)
Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
Coleman RL, Stevens RJ, Holman RR
Diabetologia 2004;47:Suppl 1:A42
40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral)
Could non-HDL cholesterol replace total/HDL cholesterol ratio to estimate coronary heart disease risk in the UKPDS risk engine?
Stevens RJ, Coleman RL, Shine BL, Holman RR
Diabetologia 2004;47:Suppl 1:A61
[Abstract]
40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral)
Risk factors for neuropathy in UKPDS
Stratton IM, Holman RR, Boulton AJM
Diabetologia 2004;47:Suppl 1:A47
[Abstract]
40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
The haemoglobin glycation index is reproducible in dysglycaemic individual but is not explained by post-challenge plasma glucose levels
Kim JI, Stevens RJ, Holman RR
Diabetologia 2004;47:Suppl 1:A122
[Abstract]
40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement
Desai M, Williams AJK, Horton VA, Bingley PJ, Levy JC, Cull CA, Holman RR, Bonifacio E, Christie MR, Clark A
Diabetologia 2004;47:Suppl 1:A186
[Abstract]
40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral)
Cost utility analysis of intensive blood-glucose control, tight blood pressure control and metformin in patients with Type 2 diabetes
Clarke PM, Gray A, Stevens RJ, Holman RR
Diabetologia 2004;47:Suppl 1:A50
[Abstract]
40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster)
A calculator for HOMA
Holman RR, Hines G, Kennedy I, Stevens RJ, Matthews D, Levy JC
Diabetologia 2004;47:Suppl 1:A222
[Abstract]

2003

16th International Diabetes Federation Congress, Paris (Poster)
Prevalence of microalbuminuria in recently diagnosed type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study
Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A326
[Abstract]
16th International Diabetes Federation Congress, Paris (Poster)
Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study
Holman RR, Kahn SE, Heise MA, Porter LE, Freed MI, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A198
[Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster)
Prevalence of microalbuminuria and its relationship to non-traditional risk factors in recently diagnosed type 2 diabetes mellitus: observations from the ADOPT study
Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group
Diabetes 2003;52:suppl:A190
[Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster)
Risk of Heart Failure in Type 2 Diabetes
Coleman R, Stevens RJ, Stratton IM, Adler A, Matthews D, Holman RR
Diabetes 2003;52:Suppl 1:A217
60th Scientific Sessions of the American Diabetes Association, Glasgow (Oral)
Six-year results from the Early Diabetes Intervention Trial
Holman RR, Blackwell L, Stratton IM, Manley SE, Tucker L, Frighi V
Diabetic Medecine 2003;20:(Suppl 2):15
[Abstract]

2002

62nd Scientific Sessions of the American Diabetes Association, San Francisco (Poster)
Forecasting Coronary Case Fatality in Type 2 Diabetes: A UKPDS Risk Engine Equation
Stevens RJ, Coleman RL, Adler AI, Stratton IM, Holman RR
Diabetes 2002;51:Suppl 2:A172
38th Annual Meeting of the European Association for the Study of Diabetes, Budapest (Poster)
The Glycaemic Optimisation Outcomes in Diabetes (GOOD) feasibility study: glucose control and weight gain in a 1 year community-based study
Potts NJ, Dudley CA, Holman RR
Diabetologia 2002;45:Suppl 2:A243
[Abstract]
38th Annual Meeting of the European Association for the Study of Diabetes, Budapest (Poster)
The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
Mohanlal N, Holman RR
Diabetologia 2002;45:Suppl 2:A246
[Abstract]
38th Annual Meeting of the European Association for the Study of Diabetes, Budapest (Poster)
The Glycaemic Optimisation Outcomes in Diabetes (GOOD) feasibility study: early use of combination therapies and insulin in general practice.
Potts NJ, Dudley CA, Holman RR
Diabetologia 2002;45:Suppl 2:A265
[Abstract]
21st Joint Meeting of the British Endocrine Societies, Harrogate, UK (Poster)
Diabetes and vascular risk
Rury R Holman
Endocrine Abstracts 2002;3:S14
193rd Meeting of the Society for Endocrinology and Society for Endocrinology joint Endocrinology and Diabetes Day, London, UK (Poster)
The Role of Metformin
RR Holman, IM Stratton
Endocrine Abstracts 2002;4:DS8

2001

37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster)
Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Cull CA, Wright AD, Macleod KM, Holman RR
Diabetologia 2001;44:Suppl 1:A217
[Abstract]
37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster)
Autoantibodies to IA2ic and to Phogrin increase the prediction for insulin requirement in patients with Type 2 Diabetes
Bosi E, Locatelli M, Cull CA, Scirpoli M, Bonifacio E, Stratton IM, Holman RR, Bottazzo GF
Diabetologia 2001;44:Suppl 1:A103
[Abstract]
37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster)
Altered postprandial responses in type 2 diabetes
Mohanlal N, Holman RR
Diabetologia 2001;44:Suppl 1:A165
[Abstract]
37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster)
Calcium/calmodulin dependent Protein Kinase II genes: genomic structure and screening for variants in subjects with type 2 diabetes
Gloyn AL, Desai M, Clark A, Holman RR, Frayling TM, Hattersley AT, Ashcroft SJH
Diabetologia 2001;44:Suppl 1:A88
[Abstract]
37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Oral)
Variation at the insulin VNTR locus but not the CTLA-4 locus is associated with age of onset and need for insulin therapy in latent autoimmune diabetes in adults (LADA)
Horton VA, Stratton IM, Owen R, Holman RR, Levy JC, Clark A
Diabetologia 2001;44:Suppl 1:A75
[Abstract]

2000

36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral)
Sulphonylurea Therapy Over Six Years Does Not Delay Progression To Diabetes
Herlihy OM, Morris RJ, Karunakaran S, Holman RR
Diabetologia 2000;43:Suppl1:A73
[Abstract]
36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Poster)
Reinforced Healthy Living Advice Over Six Years Does Not Delay Progression To Diabetes
Dyson PA, Mehta Z, Hammersley M, Holman RR
Diabetologia 2000;43:Suppl1:A114
[Abstract]
36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral)
Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
Cull CA, Wright AD, Holman RR
Diabetologia 2000;43:Suppl 1:A40
[Abstract]
36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral)
Butyrylcholinesterase K variant is associated with type 2 diabetes in UK caucasians
Hashim Y, Shepherd D, Wiltshire S, Clarke A, Holman RR
Diabetologia 2000;43:Suppl 1:A51
[Abstract]
36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral)
Possible prevention of type 2 diabetes with acarbose or metformin over three years
Citro├źn HA, Tunbridge FKE, Holman RR
Diabetologia 2000;43:Suppl 1:A73
[Abstract]
36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Poster)
ApoE ε2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes
Horton VA, Groves CJ, Naylor M, Owen R, Wiltshire S, Stratton IM, Green F, Holman RR
Diabetologia 2000;43:Suppl 1:A86
[Abstract]
36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Poster)
Standardised HbA1c measurements are essential for the management of glycaemia as a risk factor in diabetes
Manley SE, Holman RR
Diabetologia 2000;43:Suppl 1:A232
[Abstract]
60th Scientific Sessions of the American Diabetes Association, San Antonio (Poster)
Possible Prevention of Type 2 Diabetes with Acarbose or Metformin
Holman RR, North BV, Tunbridge FK
Diabetes 2000;40:(Suppl 1):A111
[Abstract]

1998

34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster)
Insulin VNTR and HLA DRB1/DQB1 loci affect age of presentation of autoimmune diabetes in adults
Horton VA, Stratton IM, Owen RJ, Bennett ST, Todd JA, Holman RR, Turner RC
Diabetologia 1998;41:Suppl 1:A105
[Abstract]
34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster)
Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients
Groves CJ, Horton VA, Ritchie A, Owen RJ, Stratton IR, Green FR, Holman RR, Turner RC
Diabetologia 1998;41:Suppl 1:A115
[Abstract]
34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster)
Retinopathy in subjects with increased fasting plasma glucose levels.
Karunakaran S, Aldington S, North B, Ryder R, Holman RR
Diabetologia 1998;41:Suppl 1:A283
[Abstract]

1976

Medical Research Society Meeting 1976, (Poster)
A New Approach to the Treatment of Mild Diabetes
Holman RR, Turner RC
Clinical Science 1976;p18
[Abstract]
Medical Research Society Meeting 1976, (Poster)
Beta Cell Deficiency in Maturity Onset Diabetes
Turner RC, Holman RR, Hockaday TDR
Clinical Science 1976;p18
[Abstract]
12th Annual Meeting of the European Association for the Study of Diabetes, Helsinki (Poster)
A New Approach to the Treatment of Mild Diabetes
Holman RR, Turner RC
Diabetologia 1976;12:398-399
[Abstract]